Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers

被引:46
|
作者
Wallis, Sebastian P. [1 ]
Stafford, Nicholas D. [2 ]
Greenman, John [3 ]
机构
[1] Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull HU16 5JQ, N Humberside, England
[2] Castle Hill Hosp, Hull York Med Sch, Daisy Labs, Kingston Upon Hull, N Humberside, England
[3] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2015年 / 37卷 / 03期
关键词
microenvironment; prognosis; cancer; head; neck; SQUAMOUS-CELL CARCINOMA; MIGRATION-INHIBITORY FACTOR; ZETA-CHAIN EXPRESSION; CD20(+) B-CELLS; CD8(+) T-CELLS; INFILTRATING LYMPHOCYTES; NASOPHARYNGEAL CARCINOMA; HUMAN-PAPILLOMAVIRUS; PROGNOSTIC VALUE; GROWTH-FACTOR;
D O I
10.1002/hed.23736
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundThe tumour microenvironment is a highly complex region where multiple interactions occur between host and cancer cells. The host response is defined by the presence and function of different tumour infiltrating lymphocytes and cytokines. Head and neck squamous cell carcinomas comprise a subgroup of human cancers with significant morbidity and mortality. MethodA literature review was performed to identify studies, which have investigated the impact of immune factors within the tumour microenvironment of head and neck squamous cell carcinomas on clinical outcomes. ResultsHigher counts of intratumoral dendritic cells and CD8+ T-lymphocytes are associated with a favorable prognosis in head and neck cancers. However, contrasting results have been found with T-regulatory cells whereby higher intratumoral counts appear favorable particularly in tumours of oropharyngeal origin. A number of studies have found a link between various biomarkers, e.g. IL-10 in oral cancers, and clinical outcome. ConclusionsWe have identified immune factors within the tumour microenvironment, which are critically related to prognosis and also those, which require further work to elucidate their full relevance. Furthermore it is clear that if immunotherapy is to be introduced as an adjunct in the treatment of head and neck cancers, different immunological parameters will need to be selected for each distinct subsite. 2014 Wiley Periodicals, Inc. Head Neck 37: 449-459, 2015
引用
收藏
页码:449 / 459
页数:11
相关论文
共 50 条
  • [1] Tumor immune microenvironment in head and neck cancers
    Chen, Samantha M. Y.
    Krinsky, Alexandra L.
    Woolaver, Rachel A.
    Wang, Xiaoguang
    Chen, Zhangguo
    Wang, Jing H.
    MOLECULAR CARCINOGENESIS, 2020, 59 (07) : 766 - 774
  • [2] The tumor immune microenvironments of HPV+ and HPV- head and neck cancers
    Gameiro, Steven F.
    Evans, Andris M.
    Mymryk, Joe S.
    WIRES MECHANISMS OF DISEASE, 2022, 14 (02):
  • [3] Immune Suppression in Head and Neck Cancers: A Review
    Duray, Anaelle
    Demoulin, Stephanie
    Hubert, Pascale
    Delvenne, Philippe
    Saussez, Sven
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2010,
  • [4] HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas
    Lechien, Jerome R.
    Descamps, Geraldine
    Seminerio, Imelda
    Furgiuele, Sonia
    Dequanter, Didier
    Mouawad, Francois
    Badoual, Cecile
    Journe, Fabrice
    Saussez, Sven
    CANCERS, 2020, 12 (05)
  • [5] Tumor microenvironment is not an 'innocent bystander' in the resistance to treatment of head and neck cancers (Review)
    Mazilu, Laura
    Suceveanu, Andra-Iulia
    Stanculeanu, Dana-Lucia
    Gheorghe, Andreea-Daniela
    Fricatel, Gabriela
    Negru, Serban-Mircea
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (04)
  • [6] Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer
    Badr, Mohamed
    Joehrens, Korinna
    Allgaeuer, Michael
    Boxberg, Melanie
    Weichert, Wilko
    Tinhofer, Ingeborg
    Denkert, Carsten
    Schirmacher, Peter
    Stenzinger, Albrecht
    Budczies, Jan
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (09) : 1443 - 1454
  • [7] Tumor Immune Microenvironment in Gynecologic Cancers
    Margul, Daniel
    Yu, Camilla
    AlHilli, Mariam M.
    CANCERS, 2023, 15 (15)
  • [8] Heterogeneity of the tumor immune microenvironment and its clinical relevance
    Jia, Qingzhu
    Wang, Aoyun
    Yuan, Yixiao
    Zhu, Bo
    Long, Haixia
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)
  • [9] Viral and Clinical Oncology of Head and Neck Cancers
    Goon, Peter
    Schurmann, Matthias
    Oppel, Felix
    Shao, SenYao
    Schleyer, Simon
    Pfeiffer, Christoph J.
    Todt, Ingo
    Brasch, Frank
    Scholtz, Lars-Uwe
    Goeerner, Martin
    Sudhoff, Holger
    CURRENT ONCOLOGY REPORTS, 2022, 24 (07) : 929 - 942
  • [10] Clinical relevance of tumor microenvironment: immune cells, vessels, and mouse models
    Katsuta, Eriko
    Rashid, Omar M.
    Takabe, Kazuaki
    HUMAN CELL, 2020, 33 (04) : 930 - 937